Cardiac Development
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Embryology and Anatomy of Fetal Heart
Prof. Saeed Abuel Makarem Dr. Jamila El Medany Objectives • By the end of this lecture the student should be able to: • Describe the formation, sit, union divisions of the of the heart tubes. • Describe the formation and fate of the sinus venosus. • Describe the partitioning of the common atrium and common ventricle. • Describe the partitioning of the truncus arteriosus. • List the most common cardiac anomalies. • The CVS is the first major system to function in the embryo. • The heart begins to beat at (22nd – 23rd ) days. • Blood flow begins during the beginning of the fourth week and can be visualized by Ultrasound Doppler Notochord: stimulates neural tube formation Somatic mesoderm Splanchnic mesoderm FORMATION OF THE HEART TUBE • The heart is the first functional organ to develop. • It develops from Splanchnic Mesoderm in the wall of the yolk sac (Cardiogenic Area): Cranial to the developing Mouth & Nervous system and Ventral to the developing Pericardial sac. • The heart primordium is first evident at day 18 (as an Angioplastic cords which soon canalize to form the 2 heart tubes). • As the Head Fold completed, the developing heart tubes change their position and become in the Ventral aspect of the embryo, Dorsal to the developing Pericardial sac. • . Development of the Heart tube • After Lateral Folding of the embryo, the 2 heart tubes approach each other and fuse to form a single Endocardial Heart tube within the pericardial sac. • Fusion of the two tubes occurs in a Craniocaudal direction. What is the • The heart tube grows faster than shape of the the pericardial sac, so it shows 5 alternate dilations separated by Heart Tube? constrictions. -
CCM2 and CCM3 Proteins Contribute to Vasculogenesis and Angiogenesis in Human Placenta
Histol Histopathol (2009) 24: 1287-1294 Histology and http://www.hh.um.es Histopathology Cellular and Molecular Biology CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta Gamze Tanriover1, Yasemin Seval1, Leyla Sati1, Murat Gunel2 and Necdet Demir1 1Department of Histology and Embryology, Akdeniz University, School of Medicine, Antalya, Turkey and 2 Department of Neurosurgery, Yale University, School of Medicine, New Haven, CT, USA Summary. Placenta as an ideal model to study Introduction angiogenic mechanisms have been established in previous studies. There are two processes, The placenta is a multifaceted organ that plays a vasculogenesis and angiogenesis, involved in blood critical role in maintaining and protecting the developing vessel formation during placental development. fetus. Normal development and function of the placenta Therefore, blood vessel formation is a crucial issue that requires extensive vasculogenesis and subsequent might cause vascular malformations. One of the vascular angiogenesis, in both maternal and fetal tissues. malformations is cerebral cavernous malformation Vasculogenesis is the formation of the primitive vascular (CCM) in the central nervous system, consisting of network de novo from progenitor cells, and angiogenesis endothelium-lined vascular channels without intervening is identified as the extension of blood vessels from normal brain parenchyma. Three CCM loci have been preexisting vascular structures (Demir et al., 1989, 2006; mapped as Ccm1, Ccm2, Ccm3 genes in CCM. In order Geva et al., 2002; Charnock-Jones et al., 2004). Many to investigate whether CCM proteins participate in blood factors, such as vascular endothelial growth factor vessel formation, we report here the expression patterns (VEGF), angiopoietins (Angpt-1 and -2) and their of CCM2 and CCM3 in developing and term human receptors are involved in the molecular regulation of placenta by means of immunohistochemistry and these diverse developmental steps. -
Goals and Outcomes – Gametogenesis, Fertilization (Embryology Chapter 1)
Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Czech Republic; License Creative Commons - http://creativecommons.org/licenses/by-nc-nd/3.0/ Goals and outcomes – Gametogenesis, fertilization (Embryology chapter 1) Be able to: − Define and use: progenesis, gametogenesis, primordial gonocytes, spermatogonia, primary and secondary spermatocytes, spermatids, sperm cells (spermatozoa), oogonia, primary and secondary oocytes, polar bodies, ovarian follicles (primordial, primary, secondary, tertiary), membrane granulosa, cumulus oophorus, follicular antrum, theca folliculi interna and externa, zona pellucida, corona radiata, ovulation, corpus luteum, corpus albicans, follicular atresia, expanded cumulus, luteinizing hormone (LH), follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG), sperm capacitation, acrosome reaction, cortical reaction and zona reaction, fertilization, zygote, cleavage, implantation, gastrulation, organogenesis, embryo, fetus, cell division, differentiation, morphogenesis, condensation, migration, delamination, apoptosis, induction, genotype, phenotype, epigenetics, ART – assisted reproductive techniques, spermiogram, IVF-ET (in vitro fertilization followed by embryo transfer), GIFT – gamete intrafallopian transfer, ICSI – intracytoplasmatic sperm injection − Draw and label simplified developmental schemes specified in a separate document. − Give examples of epigenetic mechanisms (at least three of them) and explain how these may affect the formation of phenotype. − Give examples of ethical issues in embryology (at least three of them). − Explain how the sperm cells are formed, starting with primordial gonocytes. Compare the nuclear DNA content, numbers of chromosomes, cell shape and size in all stages. − Explain how the Sertoli cells and Leydig cells contribute to spermatogenesis. − List the parameters used for sperm analysis. What are their normal values? − Explain how the mature oocytes differentiate, starting with oogonia. − Explain how the LH and FSH contribute to oogenesis. -
Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All V Integrins
Cell, Vol. 95, 507–519, November 13, 1998, Copyright ©1998 by Cell Press Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All ␣v Integrins Bernhard L. Bader,*‡ Helen Rayburn,* their ligands. Significant expression of ␣v integrins has Denise Crowley,* and Richard O. Hynes*† been noted, in particular, in neural crest cells (Delannet * Howard Hughes Medical Institute et al., 1994), glial cells (Hirsch et al., 1994; Milner and Center for Cancer Research ffrench-Constant, 1994), muscle (Hirsch et al., 1994; Mc- and Department of Biology Donald et al., 1995; Martin and Sanes, 1997), osteoclasts Massachusetts Institute of Technology (Va¨ a¨ na¨ nen and Horton, 1995), epithelia (␣v6; Breuss et Cambridge, Massachusetts 02139 al., 1995; Huang et al., 1996), and blood vessels during development (Brooks et al., 1994a; Drake et al., 1995; Friedlander et al., 1995, 1996) or angiogenesis in re- Summary sponse to tumors (Brooks et al., 1994a, 1994b, 1996, 1998; Varner et al., 1995). ␣v integrins have been implicated in many develop- Among the ligands for various ␣v integrins is fibro- mental processes and are therapeutic targets for inhi- nectin (FN), and results on mouse embryos lacking FN bition of angiogenesis and osteoporosis. Surprisingly, or FN receptor integrins suggest that ␣v integrins might ablation of the gene for the ␣v integrin subunit, elimi- be important receptors for FN during early development. nating all five ␣v integrins, although causing lethality, FN-null embryos fail to form notochord or somites allows considerable development and organogenesis (George et al., 1993; Georges-Labouesse et al., 1996), including, most notably, extensive vasculogenesis and whereas embryos null for either (Yang et al., 1993, 1995) angiogenesis. -
Copyright by Steven A. Vokes 2002 the Dissertation Committee for Steven Alexander Vokes Certifies That This Is the Approved Version of the Following Dissertation
Copyright by Steven A. Vokes 2002 The Dissertation Committee for Steven Alexander Vokes Certifies that this is the approved version of the following dissertation: The Role of Endoderm in Vascular Patterning Committee: Janice A. Fischer, Supervisor Paul A. Krieg , Co-Supervisor Alan M. Lloyd Arlen W. Johnson S. Martin Shankland R. Adron Harris The Role of Endoderm in Vascular Patterning by Steven Alexander Vokes, B.A. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin December, 2002 Dedication This work, symbolic of my higher education, is dedicated to my parents Carol and Emmett Vokes, who played such an integral role in its foundations. Acknowledgements I have been extremely fortunate to have excellent mentoring during my time in graduate school. I thank Paul Krieg for his suggestions, enthusiasm, encouragement and friendship during this learning process. He has taught me how to think (and write) critically and insightfully about science. I am also grateful to Amy Cheng Vollmer, my undergraduate mentor. She introduced me to the joys of scientific research, and continues to give me excellent advice whenever I need it most. I thank Peter Vize, whose conversations led to the first experiments described within. In daily interactions, I have benefited from a caste of talented co-workers and advisors. These include Craig Newman, Wendy Gerber, Ondine Cleaver, Tom Carroll, Eric Small, Rob Garriock, Martha Joe, Parker Antin, Ray Runyan, Jean Wilson, Carol Gregorio and all past and present members of the Krieg lab. -
Glossary of Key Terms and Concepts - Chapter 8
Glossary of Key Terms and Concepts - Chapter 8 Angioblasts - These "vessel-forming cells" may arise from any kind of mesoderm except prechordal plate mesoderm. Angioblastic cords - Angiocysts coalesce to form short blind-ended angioblastic cords. Angioblastic plexuses - Angioblastic cords coalesce to form complex interconnected vascular networks or plexuses. Angiocysts - These vesicles are formed by angioblasts during the process of vasculogenesis. Angiogenesis - This is the mechanism whereby preexisting vessels lengthen or branch by sprouting. Aortic arches - These vessels have been modified in humans to form the great vessels of the thorax (also see Ch. 7). Axis arteries - These central arteries of the limbs are derived from the 7th intersegmental arteries (upper limb) and 5th lumbar intersegmental arteries (lower limb). Blood islands - Blood islands are cysts of angioblasts containing hemoblasts. These coalesce to form blood vessels in the yolk sac and also form the coronary vasculature. Branchial arches - These are the gill bars of fish. Homologous structures of humans are more appropriately named "pharyngeal" arches. Cardinal system of veins - These veins drain the head and neck and body wall and extremities of the embryo. Anterior cardinals drain the head and neck and the trunk and lower extremities are drained by paired posterior cardinals. The posterior cardinal veins are replaced by subcardinal and supracardinal veins during the second month. Coronary vessels - These vessels of the heart form from epicardium as subepicardial plexuses fuse with sprouts of the aorta and coronary sinus to form the coronary arteries and coronary veins respectively. Endothelial cells - These cells arise from angioblasts to form the initial vascular network. -
VEGFR-3 in Angiogenesis and Lymphangiogenesis
VEGFR-3 in Angiogenesis and Lymphangiogenesis Lotta Jussila Molecular/Cancer Biology Laboratory Haartman Institute and Helsinki University Central Hospital Biomedicum Helsinki University of Helsinki Finland Academic dissertation To be publicly discussed, with the permission of the Medical Faculty of the University of Helsinki, in the lecture hall 3 of the Biomedicum Helsinki, Haartmaninkatu 8, Helsinki, on December 14th, 2001 at 12 o´clock noon. Helsinki, 2001 Supervised by Dr. Kari Alitalo Molecular/Cancer Biology Laboratory University of Helsinki Reviewed by Dr. Ulf Eriksson Ludwig Institute for Cancer Research Karolinska Institute and Dr. Hannu Sariola Institute of Biomedicine University of Helsinki Opponent Dr. Christer Betsholtz Department of Medical Biochemistry University of Göteborg ISBN 952-91-4175-0 (nid.) ISBN 952-10-0241-7 (pdf) Multiprint Oy Helsinki VEGFR-3 in Angiogenesis and Lymphangiogenesis 1 Contents Contents............................................................................................................. 1 Abbreviations ....................................................................................................... 2 List of Original Publications ...................................................................................... 3 Abstract ............................................................................................................. 4 Review of the literature .......................................................................................... 5 Blood vessel development ........................................................................... -
Cardiogenesis with a Focus on Vasculogenesis and Angiogenesis
Received: 27 August 2019 | Revised: 4 February 2020 | Accepted: 20 February 2020 DOI: 10.1111/ahe.12549 SPECIAL ISSUE Cardiogenesis with a focus on vasculogenesis and angiogenesis Katrin Borasch1 | Kenneth Richardson2 | Johanna Plendl1 1Department of Veterinary Medicine, Institute of Veterinary Anatomy, Freie Abstract University Berlin, Berlin, Germany The initial intraembryonic vasculogenesis occurs in the cardiogenic mesoderm. Here, 2 College of Veterinary Medicine, School a cell population of proendocardial cells detaches from the mesoderm that subse- of Veterinary and Life Sciences, Murdoch University, Murdoch, WA, Australia quently generates the single endocardial tube by forming vascular plexuses. In the course of embryogenesis, the endocardium retains vasculogenic, angiogenic and Correspondence Johanna Plendl, Department of Veterinary haematopoietic potential. The coronary blood vessels that sustain the rapidly ex- Medicine, Institute of Veterinary Anatomy, panding myocardium develop in the course of the formation of the cardiac loop by Freie University Berlin, Berlin, Germany. Email: [email protected] vasculogenesis and angiogenesis from progenitor cells of the proepicardial serosa at the venous pole of the heart as well as from the endocardium and endothelial cells of Funding information Freie Universität Berlin the sinus venosus. Prospective coronary endothelial cells and progenitor cells of the coronary blood vessel walls (smooth muscle cells, perivascular cells) originate from different cell populations that are in close spatial as well as regulatory connection with each other. Vasculo- and angiogenesis of the coronary blood vessels are for a large part regulated by the epicardium and epicardium-derived cells. Vasculogenic and angiogenic signalling pathways include the vascular endothelial growth factors, the angiopoietins and the fibroblast growth factors and their receptors. -
Vertebrate Embryos As Tools for Anti-Angiogenic Drug Screening and Function
Vertebrate embryos as tools for anti-angiogenic drug screening and function Shaunna Beedie1,2, Alexandra J. Diamond1, Lucas Rosa Fraga1, William D. Figg2, Neil Vargesson1, * 1 School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK. 2 Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Bethesda. USA. *Corresponding author Neil Vargesson: [email protected]; [email protected] Key words: angiogenesis, chicken, zebrafish, mouse, rat, rabbit, non-human primates, thalidomide Abstract The development of new angiogenic inhibitors highlights a need for robust screening assays that adequately capture the complexity of vessel formation, and allow for the quantitative evaluation of the teratogenicity of new anti- angiogenic agents. This review discusses the use of screening assays in vertebrate embryos, specifically focusing upon chicken and zebrafish embryos, for the detection of anti-angiogenic agents. Introduction and background The cardiovascular system is vital for normal embryonic development in utero [1]. It is one of the earliest differentiating and functioning organ systems, emphasizing its importance to the embryo [2-7]. The primitive vascular system develops by vasculogenesis, de novo differentiation and growth of vessels from the mesoderm. The major vessels in the embryo form first, the dorsal aortae (transporting oxygenated blood from the placenta or yolk sac to the heart) and vena cava or vitelline veins (transporting deoxygenated blood back to the heart or yolk sac) develop by vasculogenesis. Expansion of the nascent vascular network can then occur by angiogenesis, the process of vessel formation from the preexisting vasculature. -
Cardiovascular System Heart Development Cardiovascular System Heart Development
Cardiovascular System Heart Development Cardiovascular System Heart Development In human embryos, the heart begins to beat at approximately 22-23 days, with blood flow beginning in the 4th week. The heart is one of the earliest differentiating and functioning organs. • This emphasizes the critical nature of the heart in distributing blood through the vessels and the vital exchange of nutrients, oxygen, and wastes between the developing baby and the mother. • Therefore, the first system that completes its development in the embryo is called cardiovascular system. https://www.slideshare.net/DrSherifFahmy/intraembryonic-mesoderm-general-embryology Mesoderm is one of the three • Connective tissue primary germ layers that • Smooth and striated muscle • Cardiovascular System differentiates early in • Kidneys development that collectively • Spleen • Genital organs, ducts gives rise to all subsequent • Adrenal gland cortex tissues and organs. The cardiovascular system begins to develop in the third week of gestation. Blood islands develop in the newly formed mesoderm, and consist of (a) a central group of haemoblasts, the embryonic precursors of blood cells; (b) endothelial cells. Development of the heart and vascular system is often described together as the cardiovascular system. Development begins very early in mesoderm both within (embryonic) and outside (extra embryonic, vitelline, umblical and placental) the embryo. Vascular development occurs in many places. • Blood islands coalesce to form a vascular plexus. Preferential channels form arteries and veins. • Day 17 - Blood islands form first in the extra-embryonic mesoderm • Day 18 - Blood islands form next in the intra-embryonic mesoderm • Day 19 - Blood islands form in the cardiogenic mesoderm and coalesce to form a pair of endothelial heart tubes Development of a circulation • A circulation is established during the 4th week after the myocardium is differentiated. -
No Live Individual Homozygous for a Novel Endoglin Mutation Was Found in a Consanguineous Arab Family with Hereditary Haemorrhag
1of4 J Med Genet: first published as 10.1136/jmg.2004.022079 on 1 November 2004. Downloaded from ONLINE MUTATION REPORT No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia A Karabegovic*, M Shinawi*, U Cymerman, M Letarte ............................................................................................................................... J Med Genet 2004;41:e119 (http://www.jmedgenet.com/cgi/content/full/41/11/e119). doi: 10.1136/jmg.2004.022079 ereditary haemorrhagic telangiectasia (HHT or Rendu- Osler-Weber syndrome; MIM 187300) is characterised Key points Hby vascular dysplasia and is inherited in an autosomal dominant manner. HHT occurs among many ethnic groups N Mutation analysis was performed in a large Arab over a wide geographical area. Recent epidemiological studies family with a known history of hereditary haemor- have revealed an incidence for this disease of 1 in 5000– rhagic telangiectasia (HHT) and consanguinity. 12 8000. In most cases, the manifestations of HHT are not N A novel exon 7 missense mutation (c.932TRG) in the present at birth, but develop with age; epistaxis is usually the Endoglin (ENG) gene was found in the proband, earliest sign, often occurring in childhood, while mucocuta- suggesting HHT1. neous and gastrointestinal telangiectases develop progres- sively with age.3 Arteriovenous malformations (AVMs) in the N The mutation was present as a single allele in ten pulmonary, cerebral, or hepatic circulations account for some relatives with clinical signs of disease but was absent of the most devastating clinical complications of HHT and are from 21 unaffected family members, indicating that the due to direct connections between arteries and veins.4 The mutation segregates with the phenotype. -
In Situ Detection of Tbx5 Expression in Developing Chick Embryonic Heart
San Jose State University SJSU ScholarWorks Master's Theses Master's Theses and Graduate Research Fall 2010 In Situ Detection Of Tbx5 Expression In Developing Chick Embryonic Heart Vaishali Agarwal San Jose State University Follow this and additional works at: https://scholarworks.sjsu.edu/etd_theses Recommended Citation Agarwal, Vaishali, "In Situ Detection Of Tbx5 Expression In Developing Chick Embryonic Heart" (2010). Master's Theses. 3901. DOI: https://doi.org/10.31979/etd.84mn-c4vy https://scholarworks.sjsu.edu/etd_theses/3901 This Thesis is brought to you for free and open access by the Master's Theses and Graduate Research at SJSU ScholarWorks. It has been accepted for inclusion in Master's Theses by an authorized administrator of SJSU ScholarWorks. For more information, please contact [email protected]. IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART A Thesis Presented to The Faculty of the Department of Biological Sciences San Jose State University In Partial Fulfillment of the Requirements for the Degree Master of Science by Vaishali Agarwal December 2010 © 2010 Vaishali Agarwal ALL RIGHTS RESERVED The Designated Thesis Committee Approves the Thesis Titled IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART by Vaishali Agarwal APPROVED FOR THE DEPARTMENT OF BIOLOGICAL SCIENCES SAN JOSE STATE UNIVERSITY December 2010 Dr. Steven White Department of Biological Sciences Dr. Michael Sneary Department of Biological Sciences Dr. Bob Fowler Department of Biological Sciences ABSTRACT IN SITU DETECTION OF Tbx 5 EXPRESSION IN DEVELOPING EMBRYONIC CHICK HEART by Vaishali Agarwal The Tbx 5 gene codes for a highly conserved transcription factor containing a DNA-binding motif called the T box (or T-domain).